Debruyne Philip R, Witek Matthew, Gong Li, Birbe Ruth, Chervoneva Inna, Jin Tianru, Domon-Cell Claire, Palazzo Juan P, Freund Jean-Noel, Li Peng, Pitari Giovanni M, Schulz Stephanie, Waldman Scott A
Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Gastroenterology. 2006 Apr;130(4):1191-206. doi: 10.1053/j.gastro.2005.12.032.
BACKGROUND & AIMS: Although progression to adenocarcinoma at the gastroesophageal junction reflects exposure to acid and bile acids associated with reflux, mechanisms mediating this transformation remain undefined. Guanylyl cyclase C (GC-C), an intestine-specific tumor suppressor, may represent a mechanism-based marker and target of transformation at the gastroesophageal junction. The present studies examine the expression of GC-C in normal tissues and tumors from esophagus and stomach and mechanisms regulating its expression by acid and bile acids.
Gene expression was examined by reverse-transcription polymerase chain reaction, promoter analysis, immunohistochemistry, immunoblotting, and functional analysis. Promoter transactivation was quantified by using luciferase constructs and mutational analysis. DNA binding of transcription factors was examined by electromobility shift analysis.
GC-C mRNA and protein were ectopically expressed in approximately 80% of adenocarcinomas arising in, but not in normal, esophagus and stomach. Similarly, in OE19 human esophageal cancer cells, deoxycholate and acid induced expression of GC-C. This was associated with the induction of expression of Cdx2, a transcription factor required for GC-C expression. In turn, induction of Cdx2 expression by deoxycholate was mediated by binding sites in the proximal promoter for nuclear factor kappaB (NF-kappaB). Furthermore, deoxycholate increased NF-kappaB activity, associated with nuclear translocation and Cdx2 promoter binding of the NF-kappaB subunit p50. Moreover, a dominant negative construct for NF-kappaB prevented deoxycholate-induced p50 nuclear translocation and activation of the Cdx2 promoter.
Transformation associated with reflux at the gastroesophageal junction reflects activation by bile acid and acid of a transcriptional program involving NF-kappaB and Cdx2, which mediate intestinal metaplasia and ectopic expression of GC-C.
尽管胃食管交界部腺癌的进展反映了与反流相关的酸和胆汁酸暴露,但介导这种转变的机制仍不明确。鸟苷酸环化酶C(GC-C)是一种肠道特异性肿瘤抑制因子,可能是胃食管交界部基于机制的转化标志物和靶点。本研究检测了GC-C在食管和胃的正常组织及肿瘤中的表达,以及酸和胆汁酸调节其表达的机制。
通过逆转录聚合酶链反应、启动子分析、免疫组织化学、免疫印迹和功能分析检测基因表达。使用荧光素酶构建体和突变分析对启动子反式激活进行定量。通过电泳迁移率变动分析检测转录因子的DNA结合情况。
GC-C mRNA和蛋白在食管和胃中产生的约80%腺癌中异位表达,但在正常组织中不表达。同样,在OE19人食管癌细胞中,脱氧胆酸盐和酸诱导了GC-C的表达。这与诱导GC-C表达所需的转录因子Cdx2的表达有关。反过来,脱氧胆酸盐对Cdx2表达的诱导是由核因子κB(NF-κB)近端启动子中的结合位点介导的。此外,脱氧胆酸盐增加了NF-κB活性,这与NF-κB亚基p50的核转位和Cdx2启动子结合有关。此外,NF-κB的显性负性构建体可阻止脱氧胆酸盐诱导的p50核转位和Cdx2启动子的激活。
胃食管交界部与反流相关的转化反映了胆汁酸和酸对涉及NF-κB和Cdx2的转录程序的激活,该转录程序介导肠化生和GC-C的异位表达。